Texas 2019 - 86th Regular

Texas House Bill HB3685

Caption

Relating to pharmacy benefits provided through the Medicaid managed care program.

Impact

The proposed changes under HB 3685 are expected to have a significant impact on how pharmacy benefits are managed within the Medicaid program. With mandates for timely payment of claims and the prevention of unnecessary prior authorizations, the bill aims to streamline processes, thereby improving access to necessary medication for vulnerable populations. It also seeks to reduce barriers faced by particularly sensitive groups, such as medically fragile children, in obtaining prescribed treatments, which aligns with a broader goal of ensuring equity in healthcare access.

Summary

House Bill 3685 is directed at refining pharmacy benefits associated with the Medicaid managed care program. The bill proposes several amendments aimed at increasing transparency and accessibility for recipients when it comes to choosing pharmacies and medications. It establishes guidelines under which managed care organizations must ensure that recipients have unimpeded access to pharmacies of their choice, a key provision that seeks to address concerns about restrictive practices that limit pharmacy choice. The legislation emphasizes quality of care and mandates that managed care entities improve their response to payment claims and enhance service delivery protocols.

Sentiment

The general sentiment surrounding HB 3685 appears to be positive among advocacy groups focused on healthcare access and quality. These groups have expressed support for provisions intended to improve pharmacy access and reimbursement processes. However, there may be some contention related to the compliance burden that these changes could impose on managed care organizations, especially regarding the requirements for transparency and timely responses. This balance of improving patient access while managing organizational efficiency may fuel further discussions.

Contention

Notably, points of contention may arise regarding the bill's requirements for managed care organizations to pay liquidated damages in case of non-compliance with set standards. Critics may raise concerns about how these punitive measures could affect the funding and operational capabilities of smaller managed care providers, potentially leading to unintended consequences for service availability. Additionally, stakeholders might debate the implications for cost management within the Medicaid program, especially given the potential for increased administrative workload to adhere to the new transparency and responsiveness requirements.

Companion Bills

TX SB1096

Same As Relating to the Medicaid managed care program, including the provision of pharmacy benefits.

Previously Filed As

TX HB1283

Relating to prescription drug formularies applicable to the Medicaid managed care program.

TX SB1113

Relating to prescription drug formularies applicable to the Medicaid managed care program.

TX HB1293

Relating to the reimbursement of prescription drugs under Medicaid and the child health plan program.

TX SB2201

Relating to certain prescription drug benefits under the Medicaid managed care program.

TX HB4611

Relating to the nonsubstantive revision of the health and human services laws governing the Health and Human Services Commission, Medicaid, and other social services.

TX HB4823

Relating to the provision and delivery of benefits to certain recipients under Medicaid.

TX SB2145

Relating to the provision and delivery of benefits to certain recipients under Medicaid.

TX HB1575

Relating to improving health outcomes for pregnant women under Medicaid and certain other public benefits programs.

TX SB1239

Relating to reimbursement rates for eye health care services providers participating in the Medicaid managed care program.

TX HB3778

Relating to reimbursement rates for eye health care services providers participating in the Medicaid managed care program.

Similar Bills

TX HB3366

Relating to the reimbursement of prescription drugs under Medicaid and the child health plan program.

TX SB1612

Relating to the reimbursement of prescription drugs under the Medicaid managed care and child health plan programs.

TX HB1133

Relating to the reimbursement of prescription drugs under Medicaid and the child health plan program.

TX HB1293

Relating to the reimbursement of prescription drugs under Medicaid and the child health plan program.

TX HB3388

Relating to the reimbursement of prescription drugs under Medicaid and the child health plan program.

TX HB939

Relating to required access to care and provider network provisions in a contract between the Health and Human Services Commission and a Medicaid managed care organization.

TX SB1567

Relating to the reimbursement of prescription drugs under Medicaid and the child health plan program.

TX SB1096

Relating to the Medicaid managed care program, including the provision of pharmacy benefits.